We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OVID market cap is 52.06M. The company's latest EPS is USD -0.7371 and P/E is -0.95.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 109k | 142k | 148k | 169k | 173k |
| Operating Income | -12.03M | -18.19M | -17.42M | -20.52M | -13.23M |
| Net Income | -11.25M | -15.32M | -11.69M | 8.52M | -14.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 12.62M | 208.38M | 1.5M | 392k |
| Operating Income | -61.41M | -81.43M | 124.21M | -55.55M | -59.28M |
| Net Income | -60.46M | -81.04M | 122.84M | -54.17M | -52.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 125.03M | 144.03M | 131.61M | 118.09M | 102.65M |
| Total Liabilities | 23.74M | 56.23M | 53.33M | 29.19M | 26.36M |
| Total Equity | 101.29M | 87.8M | 78.28M | 88.9M | 76.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 80.84M | 75.93M | 194.55M | 155.27M | 144.03M |
| Total Liabilities | 10.82M | 32.29M | 14.8M | 22.99M | 56.23M |
| Total Equity | 70.02M | 43.63M | 179.75M | 132.27M | 87.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.87M | -45.78M | -16.69M | -30.94M | -45.95M |
| Investing | 45.94M | -2.58M | 20.19M | 33.01M | 33.3M |
| Financing | 502k | 30.54M | 228k | 584k | 622k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -51.09M | -51.58M | 118.61M | -55.23M | -45.78M |
| Investing | -30.04M | 34.65M | -1.82M | -87.88M | -2.58M |
| Financing | 86.54M | 47.07M | 903k | 181k | 30.54M |
| Market Cap | 52.06M |
| Price to Earnings Ratio | -0.95 |
| Price to Sales Ratio | 127.27 |
| Price to Cash Ratio | 1.84 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 71.01M |
| Average Volume (1 week) | 240.07k |
| Average Volume (1 Month) | 321k |
| 52 Week Change | -76.58% |
| 52 Week High | 4.10 |
| 52 Week Low | 0.68 |
| Spread (Intraday) | 0.15 (17.67%) |
| Company Name | Ovid Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ovidrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
